Craig S Atwood

Dr. Craig S Atwood

University of Wisconsin-Madison School of Medicine and Public Health, Laboratory for Endocrinology, Aging and Disease, William S. Middleton Memorial Veterans Hospital, GRECC 11G, 2500 Overlook Terrace, Madison, WI 53705, USA

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2019 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
BKBrian W. Kunkle
Brian W. Kunkle
T(The European Alzheimer’s Disease Initiative (Eadi)
The European Alzheimer’s Disease Initiative (Eadi)
BGBenjamin Grenier-Boley
Benjamin Grenier-Boley
RSRebecca Sims
Rebecca Sims
JBJoshua C. Bis
Joshua C. Bis
MPMargaret A. Pericak-Vance
Margaret A. Pericak-Vance

20 December 2003 in Biochemistry
Verified
Journal Article
Closed access
CACraig S Atwood
Craig S Atwood
George PerryGeorge Perry
George Perry
HZHong Zeng
Hong Zeng
YKYoji Kato
Yoji Kato
WJWalton D. Jones
Walton D. Jones
Ashley I. BushAshley I. Bush
Ashley I. Bush

1 February 2005 in Cellular and Molecular Life Sciences
Verified
Journal Article
Closed access
PDF file
SMS. Vadakkadath Meethal
S. Vadakkadath Meethal
CACraig S Atwood
Craig S Atwood

1 January 2005 in Endocrine
Verified
Journal Article
Closed access
PDF file
SMSivan Vadakkadath Meethal
Sivan Vadakkadath Meethal
MSMark A. Smith
Mark A. Smith
RBRichard L. Bowen
Richard L. Bowen
CACraig S Atwood
Craig S Atwood

1 February 2005 in Journal of Neuropathology & Experimental Neurology
Verified
Journal Article
Open access
PDF file
CACraig S Atwood
Craig S Atwood
SMSivan Vadakkadath Meethal
Sivan Vadakkadath Meethal
TLTianbing Liu
Tianbing Liu
AWAndrea C. Wilson
Andrea C. Wilson
MGMiguel Gallego
Miguel Gallego
RBRichard L. Bowen
Richard L. Bowen
Senescence is characterized neurologically by a decline in cognitive function, which we propose is the result of degenerative processes initiated by the dysregulation of the hypothalamic-pituitary-gonadal (HPG) axis with menopause and andropause. Compelling epidemiologic evidence to support this assertion includes the increased prevalence of Alzheimer disease (AD) in women, the correlation of serum HPG hormones with disease and the decreased incidence, and delay in the onset of AD following hormone replacement therapy. Dysregulation of the axis at this time leads to alterations in the concentrations of all serum HPG hormones (decreased neuronal sex steroid signaling, but increased neuronal gonadotropin releasing hormone, luteinizing hormone, and activin signaling). Hormones of the HPG axis, receptors for which are present in the adult brain, are important regulators of cell proliferation and differentiation during growth and development. Based on this, we propose that dysregulated HPG hormone signaling with menopause/andropause leads to the abortive reentry of differentiated neurons into the cell cycle via a process we term "dyosis." Interestingly, the major biochemical and neuropathologic changes reported for the AD brain also are intimately associated with neuron division: altered AβPP metabolism, Aβ deposition, tau phosphorylation, mitochondrial alterations, chromosomal replication, synapse loss, and death of differentiated neurons. Recent evidence supports the premise that AD-related biochemical changes are likely the combined result of increased mitotic signaling by gonadotropins and GnRH, decreased differentiative and neuroprotective signaling via sex steroids, and increased differentiative signaling via activins. This results in a hormonal milieu that is permissive of cell cycle reentry but does not allow completion of metaphase. Partial resetting of the axis following administration of normal endogenous sex steroids delays the onset and decreases the incidence of AD. Ideally, supplementation with HPG hormones should mimic closely the serum concentrations of all HPG hormones in reproductive men and cycling women to prevent dyotic signaling and attempted neuron division.

1 September 2019 in Nature Genetics
Verified
Journal Article
Open access
PDF file
A(Alzheimer Disease Genetics Consortium (ADGC)
Alzheimer Disease Genetics Consortium (ADGC)
BKBrian W. Kunkle
Brian W. Kunkle
T(The European Alzheimer’s Disease Initiative (Eadi)
The European Alzheimer’s Disease Initiative (Eadi)
C(Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium (CHARGE)
Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium (CHARGE)
BGBenjamin Grenier-Boley
Benjamin Grenier-Boley
MPMargaret A. Pericak-Vance
Margaret A. Pericak-Vance
An amendment to this paper has been published and can be accessed via a link at the top of the paper.